Skip to content
No Vape

Cost per additional quitter: identify both differences

Read an incremental cost-effectiveness ratio as a comparison between options, keeping its outcome and follow-up separate from the price paid by one person.

No Vape · Updated

Stack of books on a table
Illustrative image · Laura Ohlman / Unsplash

Find what additional means in the report

A comparison asks what changes when one specified option is used instead of another. The extra outcome in its denominator is relative to that alternative, not the total number of participants with the outcome. Identify both options before quoting a cost per additional outcome. The same intervention can be evaluated against different alternatives.

The original trial Targeted smoking cessation for dual users of combustible and electronic cigarettes reports intervention cost per participant separately from incremental cost per additional smoking quitter against an assessment comparison. It concerns smoking cessation among dual users. This methods example supplies no vaping-cessation effect, current service price or recommendation to use either product.

Thomas H Brandon and colleagues / Lancet Public Health: Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial

Keep two subtractions before the division

Petrou and Gray’s original economic-evaluation methods article defines the incremental ratio through a difference in costs divided by a difference in effects. The numerator and denominator therefore need the same comparison direction. A headline showing one group’s cost and calling it incremental has left out the comparison.

For a fictional arithmetic exercise, two equal-sized programs cost 1,200 and 1,000 invented currency units and record eight and six instances of an unspecified outcome. Their extra cost is 200 and their extra outcome count is two, giving 100 units per additional outcome. Dividing 1,200 by eight instead answers an average-cost question. These invented counts have no clinical meaning and are not a study result.

Stavros Petrou and Alastair Gray / BMJ: Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting

Preserve the denominator’s actual definition

In real research the outcome may be a defined smoking-abstinence measure, a vaping-abstinence measure or another quantity. Do not replace it with the broad word success. A cost per quality-adjusted life-year is another unit and cannot be renamed cost per quitter. Follow-up and analysis population also remain part of the result.

Do not reconstruct a real incremental ratio from rounded table cells or apply the simple exercise to an adjusted estimate. A small or uncertain difference in outcomes can make ratio interpretation difficult. Costs and outcomes can also move in opposite directions. Appropriate economic analysis needs the full methods and uncertainty rather than a winner selected by the smallest visible number.

Write the comparison before considering personal access

Your reading note can state the options, cost difference, outcome difference, units and period actually reported. Leave a component marked unavailable if the source does not supply it. This is a map of the published comparison, not a fresh economic analysis or a universal spending threshold.

Your own price and access remain separate questions for a current provider or store. An incremental research ratio is neither a bill nor money guaranteed to appear in your account. For consequential care or funding decisions, obtain suitable interpretation of the complete evidence. Ordinary quit preparation can use verified available support without pretending a population economic ratio is a personal offer.

Sources and scope

Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.

  1. Thomas H Brandon and colleagues / Lancet Public Health — Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial
  2. Stavros Petrou and Alastair Gray / BMJ — Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
  3. No Vape — No Vape — app features and store links

Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write